Cargando…
A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
This report describes an ongoing Phase I clinical trial testing the safety of adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) in patients with primary hepatocellular carcinoma (HCC). Fifteen HCC patients were treated with their activated and expanded TILs following...
Autores principales: | Jiang, Shan-Shan, Tang, Yan, Zhang, Yao-Jun, Weng, De-Sheng, Zhou, Zhong-Guo, Pan, Ke, Pan, Qiu-Zhong, Wang, Qi-Jing, Liu, Qing, He, Jia, Zhao, Jing-Jing, Li, Jiang, Chen, Min-Shan, Chang, Alfred E., Li, Qiao, Xia, Jian-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747409/ https://www.ncbi.nlm.nih.gov/pubmed/26515587 |
Ejemplares similares
-
Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis
por: Zhang, Xiao-Fei, et al.
Publicado: (2016) -
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014) -
Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015) -
Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
por: Zhao, Jing-Jing, et al.
Publicado: (2014) -
The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2016)